Innovating Works

MEDIAGNOST

A stranger
mtFOIE GRAS: mitoFOIE GRAS Non invasive Profiling of Mitochondrial Function in Non Alcoholic Fatty Liver Disease MEDIAGNOST GESELLSCHAFT FUR FORSCHUNG UND HERSTELLUNG VON DIAGNOSTIKA GMBH participó en un H2020 H2020-MSCA-RISE-2016 "Non-Alcoholic Fatty Liver Disease (NAFLD), including its more pathologic consequence, non-alcoholic steatohepatitis (NASH), is believed to...
2016-12-05 - 2022-08-31 | financed
Foie Gras: Bioenergetic Remodeling in the Pathophysiology and Treatment of Non Alcoholic Fatty Liver Disease MEDIAGNOST GESELLSCHAFT FUR FORSCHUNG UND HERSTELLUNG VON DIAGNOSTIKA GMBH participó en un H2020 H2020-MSCA-ITN-2016 FOIE GRAS provides innovative training for 13 early stage researchers (ESRs) to answer two critical and unanswered questions: a) Is hepatic...
2016-08-29 - 2021-06-30 | financed
Vaprosep: Validation of Progranulin as Biomarker in Diagnostics and Prognosis of Sepsis MEDIAGNOST GESELLSCHAFT FUR FORSCHUNG UND HERSTELLUNG VON DIAGNOSTIKA GMBH processed a H2020 H2020-SMEInst-2014-2015 Sepsis is a complex, systemic and inflammatory host reaction on an infection and with worldwide 1.5 million cases per year a health challeng...
2015-04-13 - 2015-09-30 | financed
PREVENTROP: New approach to treatment of the blinding disease Retinopathy of Prematurity ROP MEDIAGNOST GESELLSCHAFT FUR FORSCHUNG UND HERSTELLUNG VON DIAGNOSTIKA GMBH participó en un FP7 The overall objective is to develop a novel preventative intervention for the blinding disease retinopathy of prematurity (ROP) and other co...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.